NCT07323355

Brief Summary

Cesarean delivery (CD) is one of the most commonly performed surgical procedures worldwide, with a rising incidence particularly in high-income countries. Although often life-saving, cesarean delivery carries both short- and long-term maternal risks. Early complications include infection, hemorrhage, and thromboembolism, while inadequate uterine healing can lead to future complications such as uterine rupture and placenta accreta spectrum disorders. Additionally, cesarean scars may result in pregnancy complications, isthmocele formation, postmenstrual bleeding, pelvic pain, and dysmenorrhea. This highlights the need for optimization of the surgical technique. Despite increasing cesarean rates, there is no consensus on the optimal uterine closure method. Techniques vary in terms of the number of layers, suture locking style, and inclusion of the endometrium, and their comparative effectiveness in reducing scar defects remains unclear. Some previous studies have reported increased uterine rupture risk with single-layer locked sutures and better healing with double-layer closure, while others found no significant difference in scar outcomes. This study aims to investigate the effects of single- versus double-layer cesarean scar closure on myometrial thickness and its clinical implications.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
102

participants targeted

Target at P50-P75 for not_applicable

Timeline
6mo left

Started Nov 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress48%
Nov 2025Nov 2026

Study Start

First participant enrolled

November 11, 2025

Completed
22 days until next milestone

First Submitted

Initial submission to the registry

December 3, 2025

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 7, 2026

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 21, 2026

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 15, 2026

Last Updated

January 7, 2026

Status Verified

December 1, 2025

Enrollment Period

10 months

First QC Date

December 3, 2025

Last Update Submit

December 29, 2025

Conditions

Keywords

Caesarean SectionCesarean Scar ClosureIsthmococeleMyometrial Thickness

Outcome Measures

Primary Outcomes (1)

  • Myometrial Thickness at Cesarean Scar Site

    Myometrial thickness at the cesarean scar site will be measured using transvaginal ultrasonography (TVUSG) by a qualified obstetrician at 6 months after surgery to compare the effects of single-layer versus double-layer cesarean scar closure. Measurement Tool / Parameter: TVUSG; residual myometrial thickness (mm). Units of Measure: Millimeters (mm).

    6 months postoperatively

Secondary Outcomes (4)

  • Cesarean Scar-Related Symptoms

    6 months postoperatively

  • Cesarean Scar Defect (Isthmocele)

    6 months postoperatively

  • Major Uterine Scar-Related Complications

    Up to 6 months postoperatively

  • Morphological Characteristics of Cesarean Scar Defect

    6 months postoperatively

Study Arms (2)

Double-Layer Cesarean Scar Repair

EXPERIMENTAL

Participants in this arm receive double-layer closure of the cesarean section scar according to the study protocol. Outcomes such as myometrial thickness, scar integrity, and clinical parameters are measured. This arm is compared in parallel with the single-layer cesarean scar repair arm.

Procedure: Double-Layer Cesarean Scar Repair

Single-Layer Cesarean Scar Repair

EXPERIMENTAL

Participants in this arm receive single-layer closure of the cesarean section scar according to the study protocol. Outcomes such as myometrial thickness, scar integrity, and clinical parameters are measured. This arm is compared in parallel with the double-layer cesarean scar repair arm.

Procedure: Single-Layer Cesarean Scar Repair

Interventions

Participants in this arm undergo double-layer closure of the uterine incision during cesarean delivery. The procedure involves suturing the full thickness of the myometrium in the first layer, followed by a second continuous suture approximating the outer myometrium and serosa. Outcomes such as myometrial thickness, scar integrity, and clinical parameters are measured. This arm is compared in parallel with the single-layer cesarean scar repair arm.

Double-Layer Cesarean Scar Repair

Participants in this arm undergo single-layer closure of the uterine incision during cesarean delivery. The procedure involves a single continuous suture approximating the full thickness of the uterine wall. Outcomes such as myometrial thickness, scar integrity, and clinical parameters are measured. This arm is compared in parallel with the double-layer cesarean scar repair arm.

Single-Layer Cesarean Scar Repair

Eligibility Criteria

Age18 Years - 44 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsThis study includes female participants only, as it investigates the effects of single-layer versus double-layer cesarean scar repair on uterine myometrial thickness and related clinical outcomes. Only women who are undergoing cesarean delivery and meet the inclusion criteria are eligible for participation.
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Female participants aged 18-44 years.
  • Undergoing cesarean delivery at the study hospital's Obstetrics and Gynecology clinic.
  • Evaluated as clinically eligible based on history, physical examination, abdominal ultrasonography, and routine preoperative laboratory tests, including:
  • Complete blood count (CBC), biochemical profile, prothrombin time (PT), activated partial thromboplastin time (aPTT), blood group determination. No abnormalities detected in the above assessments.

You may not qualify if:

  • \- Presence of chronic diseases, including: Rheumatologic diseases, renal failure, vascular malformations, hypertension, cardiac disease, diabetes mellitus, obesity, thyroid disease, congenital hematologic disorders.
  • Suspected or confirmed placenta previa or placenta accreta spectrum.
  • Clinical chorioamnionitis.
  • Anterior wall uterine myomas.
  • History of low transverse nonstandard uterine incision.
  • Predicted obstetric hemorrhage or other intraoperative complications.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ankara Bilkent City Hospital

Ankara, Not Valid, 06100, Turkey (Türkiye)

RECRUITING

Study Officials

  • Merve Didem Eşkin Tanrıverdi

    Ankara City Hospital Bilkent

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Merve Didem Eşkin Tanrıverdi, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Medical Doctor

Study Record Dates

First Submitted

December 3, 2025

First Posted

January 7, 2026

Study Start

November 11, 2025

Primary Completion (Estimated)

September 21, 2026

Study Completion (Estimated)

November 15, 2026

Last Updated

January 7, 2026

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

IPD are available which may be shared in necessary conditions.

Locations